Skip to content

Study · Observational study · 2025

1 result

Drugs and patient's dissatisfaction reporting: From a disproportionality pharmacovigilance analysis to social pharmacology.

Montastruc JL

Therapie1 May 2025

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanObservational studyOther

    In adult pharmacovigilance reports, plecanatide exposure was significantly linked to patient dissatisfaction and was among drugs with the highest reporting odds ratios.

    In plain wordsIn adult pharmacovigilance reports, plecanatide was linked to patient dissatisfaction.

    Outcome
    IncreasePatient dissatisfaction reporting
    Study

    n: not reported in source

    Outcome group
    Patient-reported outcomes · Whole body
    Studied dose
    Dose not stated

    Source sentences

    Summary
    A significant association was found with 22 drugs with the highest ROR values for plecanatide, efinaconazole and avatrombopag.
    2 context sentences
    Summary · context
    Using the World Health Organization (WHO) global pharmacovigilance database, we investigated, through disproportionality analyses, potential associations between exposure to drugs and "patient dissatisfaction with treatment" reports.
    Summary · context
    All reports of "patient dissatisfaction with treatment" in adults until 31/12/2024 were included.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.